Pemphigus Vulgaris: Causes, Symptoms and Treatment
Pemphigus vulgaris is a rare, severe autoimmune disease of the skin and mucous membranes that causes painful blisters. Early diagnosis and treatment are essential for a good outcome.
Things worth knowing about "Pemphigus vulgaris"
Pemphigus vulgaris is a rare, severe autoimmune disease of the skin and mucous membranes that causes painful blisters. Early diagnosis and treatment are essential for a good outcome.
What is Pemphigus Vulgaris?
Pemphigus vulgaris is a rare, chronic autoimmune disease that affects the skin and mucous membranes. The immune system mistakenly produces antibodies against specific proteins called desmogleins, which normally hold skin cells together. This causes the upper layers of skin cells to separate, resulting in large, fragile blisters that rupture easily. Without adequate treatment, the disease can be life-threatening.
Causes
The exact cause of pemphigus vulgaris is not fully understood. It is an autoimmune condition in which the body produces antibodies -- primarily against desmoglein 1 and desmoglein 3 -- that attack the connections between skin cells. Known risk factors and potential triggers include:
- Genetic predisposition (more common in certain ethnic groups, such as Ashkenazi Jews or people from the Mediterranean region)
- Certain medications (e.g., penicillamine, ACE inhibitors)
- Possible environmental triggers or infections in genetically susceptible individuals
Symptoms
The symptoms of pemphigus vulgaris can vary depending on the stage of the disease and may include:
- Painful, flaccid blisters on the skin and mucous membranes, often first appearing in the mouth
- Erosions and raw sores after blisters rupture, which are slow to heal
- Pain when eating, drinking, or speaking (when mucous membranes are affected)
- Positive Nikolsky sign: gentle rubbing or pressure causes the outer layer of skin to slide or peel away
- General malaise and possible weight loss due to pain while eating
Diagnosis
Diagnosing pemphigus vulgaris typically involves several steps:
- Clinical examination: Assessment of blister appearance and the Nikolsky sign by a dermatologist
- Skin biopsy: A small tissue sample is examined under a microscope; characteristic findings include suprabasal acantholysis (splitting of skin cells just above the basal layer)
- Direct immunofluorescence: Detection of antibody deposits within the skin tissue
- Blood tests (indirect immunofluorescence / ELISA): Detection of circulating antibodies against desmoglein 1 and 3 in the bloodstream
Treatment
Treatment of pemphigus vulgaris aims to control blister formation, relieve pain, and prevent complications. Therapy is usually long-term and may include:
Pharmacological Treatment
- Corticosteroids (e.g., prednisolone): First-line therapy that suppresses the excessive immune response. High doses are often required initially, with gradual tapering over time.
- Immunosuppressants (e.g., azathioprine, mycophenolate mofetil): Used in combination with corticosteroids to reduce required steroid doses and minimize side effects.
- Rituximab: A monoclonal antibody that selectively targets and depletes B cells (the producers of the harmful antibodies). Now considered a key treatment option, including as a first-line therapy in some cases.
- Intravenous immunoglobulins (IVIG): Used in severe or treatment-resistant cases
- Plasmapheresis: Removal of harmful antibodies from the blood in severe disease
Wound Care and Supportive Measures
- Regular wound care to prevent infections
- Pain management and nutritional support when mucous membranes are affected
- Regular follow-up appointments with a dermatologist
Prognosis
With modern treatment, the prognosis of pemphigus vulgaris has improved significantly. Historically, the disease was often fatal; today, many patients achieve complete or partial remission. However, relapses can occur, making long-term medical monitoring essential.
References
- Murrell DF et al. - Diagnosis and evaluation of autoimmune blistering diseases. Journal of the American Academy of Dermatology, 2020.
- Hertl M et al. - Pemphigus. S2k-Guideline of the German Dermatological Society (DDG), 2020.
- World Health Organization (WHO) - Rare Diseases: Pemphigus vulgaris. WHO Global Report, 2022.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pemphigus vulgaris